Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHays Regulatory News (HAS)

Share Price Information for Hays (HAS)

Share Price is delayed by 15 minutes
Get Live Data
33.84    -0.40 (-1.17%)
Bid:
34.14
Ask:
34.72
Spread: 0.58 (1.699%)
Market Cap: £541.11m
HAS Live PriceLast checked at - London Stock Exchange

Intraday Hays Share Chart

Board Changes

16 Jan 2025 07:00

RNS Number : 4829T
Hays PLC
16 January 2025
 

16 January 2025

 

HAYS PLC

BOARD CHANGES

Hays plc ("Hays") today announces the appointment of Michael Findlay to its Board as a Non-Executive Director and Chair-designate. He will join the Board on 20 January 2025 and will succeed Andrew Martin as Non-Executive Chair from 1 May 2025. Andrew will retire on 1 May 2025 after nearly 8 years on the Board.

Michael Findlay is currently Non-Executive Chair of London Stock Exchange plc and a Non-Executive Director of International Distribution Services plc and Jarrold & Sons Limited. Michael is also Chair of Morgan Sindall Group plc but announced yesterday that he will be stepping down from the Board on 28 July 2025. Previous roles include co-head of investment banking for UK and Ireland at Bank of America and Senior Independent Director at UK Mail Group plc.

Cheryl Millington, Hays' Senior Independent Director, who led the succession process, said: "I am delighted that Michael will be joining the Hays Board. Michael is a highly accomplished business leader and a proven Non-Executive and Chair. Having spent his executive career in corporate broking and investment banking, Michael has advised many leading UK plcs on a wide range of strategic, financing and governance matters. He also brings a strong understanding of people intensive and service orientated businesses."

"I also want to take this opportunity to thank Andy on behalf of the Board for his exemplary leadership, during a period of significant change for the Group, and wish him all the very best for the future."

Michael said: "I am delighted to be joining Hays and I look forward to working with the Board and the executive team to drive forward the Group's strategy to create significant value for all stakeholders."

Andy Martin commented: "It has been a privilege to serve on the Board of Hays for nearly 8 years. It is a great company and I wish all of the incredible team every success for the future, and wish Michael all the very best as he leads the Board on this next important step of the Hays journey."

This announcement is made in accordance with Listing Rule 6.4.6. There are no further matters to be disclosed under Listing Rule 6.4.8.

 

Enquiries

Hays plc

Rachel FordKean Marden

FGS GlobalGuy Lamming / Anjali Unnikrishnan / Richard Crowley

 

General Counsel & Company Secretary

Head of Investor Relations & ESG

 

+44 (0) 333 010 2682

+44 (0) 333 010 7092hays@fgsglobal.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUVANRVAUAAAR
Date   Source Headline
20th Nov 202012:15 pmRNSDirector/PDMR Shareholding
19th Nov 20209:24 amRNSHolding(s) in Company
11th Nov 20201:12 pmRNSResult of AGM
9th Nov 20205:05 pmRNSTransaction in Own Shares
6th Nov 20204:57 pmRNSTransaction in Own Shares
5th Nov 20205:14 pmRNSTransaction in Own Shares
4th Nov 20204:56 pmRNSTransaction in Own Shares
3rd Nov 20205:01 pmRNSTransaction in Own Shares
2nd Nov 20205:03 pmRNSTransaction in Own Shares
2nd Nov 20209:59 amRNSTotal Voting Rights
30th Oct 20204:56 pmRNSTransaction in Own Shares
29th Oct 20205:00 pmRNSTransaction in Own Shares
28th Oct 20205:06 pmRNSTransaction in Own Shares
27th Oct 20205:01 pmRNSTransaction in Own Shares
26th Oct 20205:25 pmRNSTransaction in Own Shares
23rd Oct 20205:15 pmRNSTransaction in Own Shares
22nd Oct 20205:04 pmRNSTransaction in Own Shares
21st Oct 20205:05 pmRNSTransaction in Own Shares
20th Oct 20204:50 pmRNSTransaction in Own Shares
19th Oct 20205:00 pmRNSTransaction in Own Shares
16th Oct 20205:10 pmRNSTransaction in Own Shares
15th Oct 20207:00 amRNSFirst Quarter Trading Update
8th Oct 20204:59 pmRNSAnnual Financial Report
1st Oct 202010:00 amRNSTotal Voting Rights
30th Sep 20205:06 pmRNSTransaction in Own Shares
29th Sep 20204:58 pmRNSTransaction in Own Shares
28th Sep 20205:07 pmRNSTransaction in Own Shares
25th Sep 20205:02 pmRNSTransaction in Own Shares
24th Sep 20205:13 pmRNSTransaction in Own Shares
23rd Sep 20205:25 pmRNSTransaction in Own Shares
23rd Sep 20208:00 amRNSTreasury Share Purchase Programme
18th Sep 20202:49 pmRNSDirector/PDMR Shareholding
17th Sep 20209:15 amRNSDirector/PDMR Shareholding
11th Sep 202011:45 amRNSDirector/PDMR Shareholding
9th Sep 20209:25 amRNSDirector/PDMR Shareholding
1st Sep 202010:02 amRNSDirector Declaration
1st Sep 202010:00 amRNSTotal Voting Rights
27th Aug 20207:00 amRNSFinal Results
10th Aug 202012:30 pmRNSBlock listing Interim Review
5th Aug 20209:22 amRNSHolding(s) in Company
3rd Aug 202010:00 amRNSTotal Voting Rights
16th Jul 20207:00 amRNSFourth Quarter Trading Update
1st Jul 202010:00 amRNSTotal Voting Rights
1st Jun 202010:00 amRNSTotal Voting Rights
1st May 202010:00 amRNSTotal Voting Rights
9th Apr 202012:56 pmRNSHolding(s) in Company
7th Apr 20203:38 pmRNSDirector/PDMR Shareholding
3rd Apr 202010:40 amRNSDirector/PDMR Shareholding
2nd Apr 20202:34 pmRNSResults of the Placing
2nd Apr 20207:01 amRNSProposed Placing of Ordinary Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.